EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Frontage Holdings's Enterprise Value is HK$3,314 Mil.
Frontage Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$145 Mil. Therefore, Frontage Holdings's EV-to-FCF for today is 22.83.
The historical rank and industry rank for Frontage Holdings's EV-to-FCF or its related term are showing as below:
HKSE:01521'
s EV-to-FCF Range Over the Past 10 Years
Min: -171.12 Med: 51.25 Max: 216.36
Current: 22.83
During the past 8 years, the highest EV-to-FCF of Frontage Holdings was 216.36. The lowest was -171.12. And the median was 51.25.
HKSE:01521's EV-to-FCF is ranked worse than 69.74% of 390
companies
in the Biotechnology industry
Industry Median: 4.475
vs HKSE:01521: 22.83
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Frontage Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Frontage Holdings's EV-to-FCF
For the Biotechnology subindustry, Frontage Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's EV-to-FCF falls into.
Frontage Holdings's current Enterprise Value is HK$3,314 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Frontage Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$145 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Frontage Holdings's PE Ratio for today is calculated as:
Frontage Holdings's share price for today is HK$1.28.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Frontage Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Frontage Holdings EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Frontage Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Frontage Holdings (HKSE:01521) Business Description
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01521 has been successfully added to your 